AstraZeneca commits to becoming carbon negative by 2030

The pharmaceutical giant has stepped up its existing science-based targets to aim for the ambitious goal, with a preliminary target to become net zero by 2025

AstraZeneca has committed to becoming carbon negative by 2030.

The pharmaceutical giant has stepped up its existing science-based targets to aim for the ambitious goal - it plans to double energy productivity, decarbonise heat and power with renewable electricity and switch to a fleet of electric vehicles (EVs) five years earlier than it originally scheduled.

The firm aims to invest up to $1bn (£764m) to achieve these goals.

Latest Podcast